Over the past few years, glutathione has surged in popularity, especially after making a mark in Indian pop culture through ...

Cambridge Healthcare Innovations (CHI) announced the availability of its dry powder inhaler (DPI) engine for clinical trials ...

Revumenib, an oral targeted therapy for rare leukemias, is projected to be cost-neutral for health plans over 3 years, ...

During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

A man has shared how his beloved husband died after flu-like symptoms turned out to be deadly cancer. Brendan Hulse-Lewis had ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

An expert emphasizes that treatment decisions for metastatic castration-resistant prostate cancer (mCRPC) are highly ...

FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...

Philadelphia-based Fox Chase Cancer Center has opened a new oncology satellite pharmacy, tripling its capacity to prepare chemotherapy and intravenous medications. The facility, unveiled at a press ...

Prior authorization varies by plan but often requires patients or their providers to get permission (also called ...

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA ...